Options Prospectus
Released
Released
Announcement PDF
TRANSACTION SPECIFIC PROSPECTUS
Recce Pharmaceuticals Ltd
ACN 124 849 065
The Prospectus contains an offer of:
(a) 5,000,000 new Attaching Options for nil consideration, each exercisable at $0.60 and expiring on
30 June 2027, on the basis of one Attaching Option for every two Shares issued to Placement
Participants under the Placement (Placement Attaching Options);
(b) 125,000 new Attaching Options for nil consideration, each exercisable at $0.60 and expiring on 30
June 2027, on the basis of one Attaching Option for every two Consultant Shares issued to Spark
Plus (Spark Plus Options); and
(c) up to 10,250,000 new Piggyback Options for nil consideration, each exercisable at $1.00 and
expiring on 30 June 2028, being two Piggyback Options for every Attaching Option exercised
(Piggyback Options),
(together the Offers).
The Offers open on 4 November 2026.
The Offers close at 5.00 pm (AEDT) on 12 November 2026.
This Prospectus has been prepared for the purposes of making the Offers and to facilitate secondary
trading of the Shares issued on the exercise of the Options.
IMPORTANT NOTICES
This Prospectus contains important information about the Offers and should be read in its entirety. If,
after reading this Prospectus, you have any questions about the Options being offered under this
Prospectus or any other matter relating to the Offers, then you should consult your professional adviser.
An investment in the Options offered under this Prospectus should be considered speculative. The
Company will not apply for quotation of the Attaching Options or the Piggyback Options on ASX.
Accordingly, the Options will be unlisted and cannot be traded on ASX.
This Prospectus has been prepared in accordance with section 713 of the Corporations Act.
Contents
1. KEY DETAILS OF THE OFFERS.......................................................................................................1
1.1 Key terms of the Offers..................................................................................................1
1.2 Key indicative dates .......................................................................................................1
2. IMPORTANT INFORMATION .......................................................................................................2
2.1 General...........................................................................................................................2
2.2 Exposure Period.............................................................................................................2
2.3 No investment or financial product advice....................................................................2
2.4 Disclosure.......................................................................................................................2
2.5 Publicly available information .......................................................................................2
2.6 Disclaimer ......................................................................................................................3
2.7 Offer restrictions............................................................................................................3
2.8 Prospectus availability ...................................................................................................3
2.9 Forward-looking statements .........................................................................................3
2.10 Risk factors.....................................................................................................................4
2.11 Defined terms, currency and time.................................................................................4
2.12 Past performance...........................................................................................................4
2.13 No cooling-off rights apply to the Offers.......................................................................4
2.14 Withdrawal ....................................................................................................................4
2.15 Enquiries ........................................................................................................................4
3. OVERVIEW OF THE OFFERS.........................................................................................................5
3.1 The Offers ......................................................................................................................5
4. DETAILS OF THE OFFERS .............................................................................................................6
4.1 Offers .............................................................................................................................6
4.2 Eligibility to participate in the Offers.............................................................................8
4.3 Purpose of the Offers.....................................................................................................9
4.4 Use of funds...................................................................................................................9
4.5 Opening and Closing Dates for the Offers ...................................................................10
4.6 No transfer of entitlements under the Offers .............................................................10
4.7 Issue Date.....................................................................................................................10
4.8 No cooling-off rights ....................................................................................................10
4.9 No underwriting...........................................................................................................10
4.10 ASX Quotation..............................................................................................................10
4.11 Brokerage and stamp duty costs .................................................................................11
4.12 Minimum and maximum subscription.........................................................................11
4.13 Application for Options................................................................................................11
4.14 Withdrawal ..................................................................................................................11
4.15 Enquiries ......................................................................................................................12
5. EFFECT OF THE OFFERS.............................................................................................................12
ii
5.1 Reasons for the Offers.................................................................................................12
5.2 Effect on capital structure ...........................................................................................12
5.3 Effect on control ..........................................................................................................12
5.4 Effect on financial position ..........................................................................................13
6. RIGHTS AND LIABILITIES ATTACHING TO THE OPTIONS ...........................................................13
6.1 Summary of the rights and liabilities attaching to the Attaching Options ..................13
6.2 Summary of the rights and liabilities attaching to the Piggyback Options..................15
7. RIGHTS AND LIABILITIES ATTACHING TO SHARES.....................................................................17
7.1 Summary of the rights and liabilities attaching to Shares...........................................17
8. RISK FACTORS............................................................................................................................19
8.1 Introduction.................................................................................................................19
8.2 Specific risks.................................................................................................................19
8.3 General risks.................................................................................................................24
8.4 Other risks....................................................................................................................25
9. ADDITIONAL INFORMATION.....................................................................................................26
9.1 Continuous disclosure obligations ...............................................................................26
9.2 Market price of Shares.................................................................................................27
9.3 Details of substantial holders ......................................................................................28
9.4 Interests of Directors ...................................................................................................28
9.5 Consents ......................................................................................................................30
9.6 Expenses of the Offers.................................................................................................31
9.7 Financial forecasts .......................................................................................................31
9.8 Determination by ASIC.................................................................................................31
9.9 Clearing House Electronic Sub-Register System (CHESS) and Issuer
Sponsorship..................................................................................................................31
9.10 Privacy Act....................................................................................................................31
9.11 Governing law..............................................................................................................32
9.12 Litigation ......................................................................................................................32
9.13 Electronic Prospectus...................................................................................................32
9.14 Alteration of terms ......................................................................................................32
10. DIRECTORS’ CONSENT...............................................................................................................32
11. DEFINITIONS..............................................................................................................................34
12. CORPORATE DIRECTORY...........................................................................................................37
1
1. KEY DETAILS OF THE OFFERS
1.1 Key terms of the Offers
Detail Terms
Exercise Price per Attaching Option $0.60
Exercise Price per Piggyback Option $1.00
Maximum number of Attaching Options
issued under this Prospectus
5,125,000
Maximum number of Piggyback Options
issued under this Prospectus
10,250,000
Maximum gross proceeds of the Offers No funds will be raised through the
issue of Options under the Offers.
1.2 Key indicative dates
Action Date
Lodgement of the Prospectus with ASIC and
release to ASX
4 November 2026
Exposure Period ends 11 November 2026
Opening Date of the Offers 4 November 2026
Closing Date of the Offers (5:00pm (AEDT)) 12 November 2026
Issue date of Attaching Options under the Offers On or around 13 November 2026
Issue date of Piggyback Options under the Offers If, when and as the Attaching Options
are exercised in accordance with their
terms, and in any event within 10
Trading Days after the exercise of the
last Attaching Option to be exercised
on or before 30 June 2027
The above dates are indicative only and may be subject to change. Subject to the Corporations
Act, the ASX Listing Rules and other applicable laws, the Company reserves the right to close the
Offers early, extend the Offers, or accept late Applications, either generally or in particular
cases, without notification. To the extent legally permitted, the Company will treat applications
to participate in the Placement as Applications and will not require those participants to submit
a further Application. No Application will be processed until after the Exposure Period has
ended. The Company will not apply for quotation of the Attaching Options or the Piggyback
Options on ASX.
You cannot, in most circumstances, withdraw an Application once it has been accepted. No
cooling-off rights apply to the Offers.
2
2. IMPORTANT INFORMATION
2.1 General
This Prospectus is dated 4 November 2026 and was lodged with the ASIC on that date. ASIC,
ASX and their respective officers do not take any responsibility for the contents of this
Prospectus or the merits of the investment to which the Prospectus relates.
2.2 Exposure Period
The Corporations Act prohibits the Company from processing Applications during the period of
7 days after the date of lodgement of this Prospectus with ASIC. ASIC may extend that period
by up to a further 7 days (Exposure Period).
The purpose of the Exposure Period is to enable this Prospectus to be examined by market
participants before Applications are processed. That examination may result in the
identification of deficiencies in this Prospectus, in which case any Application received may
need to be dealt with in accordance with section 724 of the Corporations Act.
Applications received during the Exposure Period will not be processed until after the Exposure
Period has ended. No preference will be conferred on an Application received during the
Exposure Period, and no Options will be issued under this Prospectus before the Exposure
Period has ended.
2.3 No investment or financial product advice
The information contained in this Prospectus is not financial product advice or investment
advice and does not take into account your financial or investment objectives, financial
situation or particular needs (including financial or taxation issues). You should seek
professional advice from your accountant, financial adviser, stockbroker, lawyer or other
professional adviser before deciding to subscribe for the Options under this Prospectus to
determine whether it meets your objectives, financial situation and needs.
2.4 Disclosure
This Prospectus is a transaction specific prospectus for an offer of options to acquire
continuously quoted securities (as defined in the Corporations Act) and has been prepared in
accordance with section 713 of the Corporations Act.
Section 713 allows the issue of a more concise prospectus in relation to an offer of continuously
quoted securities. It does not contain the same level of disclosure as an initial public offering
prospectus and is only required to contain certain information in relation to the effect of the
issue of the Options by the Company, and the rights and liabilities attaching to the Options and
the Shares which will be issued upon the exercise of the Options. The Prospectus does not need
to include general information in relation to all of the assets and liabilities, financial position,
profits and losses or prospects of the Company.
Representations contained in this Prospectus are made taking into account that the Company
is a disclosing entity for the purposes of the Corporations Act and certain matters are publicly
available information or may reasonably be expected to be known to investors and professional
advisers whom prospective investors may consult.
2.5 Publicly available information
The Prospectus should be read in conjunction with the Company's continuous disclosure
announcements made by the Company which are available on the Company’s website,
https://www.recce.com.au/company-announcements/ as well as the ASX market
announcements platform available to view via the ASX website (at www.asx.com.au - ASX Code:
RCE).
3
The Company may release further announcements after the date of this Prospectus which may
be relevant to your consideration of the Offers. Potential Applicants are encouraged to check
whether any new announcements have been released by the Company after the date of this
Prospectus before deciding on whether or not to participate in the Offers.
2.6 Disclaimer
No person is authorised to give any information or to make any representations in connection
with this Prospectus. Any information or representation not contained in this Prospectus may
not be relied on as having been authorised by the Company in connection with this Prospectus.
2.7 Offer restrictions
The Offers do not constitute an offer in any place in which, or to any person to whom, it would
not be lawful to make such an offer of the Options. No action has been taken to register the
Offers or otherwise permit the Offers to be made in any jurisdiction outside Australia. The
distribution of this Prospectus in jurisdictions outside Australia may be restricted by law in
those jurisdictions and therefore persons who come into possession of this Prospectus should
seek advice on and observe any of these restrictions. Failure to comply with these restrictions
may violate securities laws.
Residents of countries outside Australia should consult their professional advisers as to
whether any government or other consents are required, or whether any formalities need to
be observed should they wish to make an Application. Submitting a duly completed Application
Form will be taken to constitute a representation and warranty that there has been no breach
of such laws and that all necessary approvals and consents have been obtained.
2.8 Prospectus availability
The Company will only make Offers under this Prospectus to those specific investors invited by
the Directors to subscribe for the Options pursuant to this Prospectus. Accordingly, if you have
not been invited by the Directors to subscribe for the Options pursuant to this Prospectus, you
cannot subscribe for the Options pursuant to this Prospectus.
To the extent legally permitted, the Company will treat applications to participate in the
Placement as Applications and will not require a further Application to be submitted.
The right to participate in the Offers is not transferable.
Please carefully read and follow the instructions in this Prospectus.
2.9 Forward-looking statements
This Prospectus contains forward-looking statements which are identified by words such as
“may”, “could”, “believes”, “estimates”, “targets”, “expects”, or “intends” and other similar
words that involve risks and uncertainties.
These statements are based on an assessment of present economic and operating conditions
and on a number of assumptions regarding future events and actions that, as at the date of this
Prospectus, are expected to take place.
Such forward-looking statements are not guarantees of future performance and involve known
and unknown risks, uncertainties, assumptions and other important factors, many of which are
beyond the control of the Company and the Directors and management of the Company.
To the maximum extent permitted by law, none of the Company or any person named in this
Prospectus or any person involved in the preparation of this Prospectus makes any
representation or warranty (express or implied) as to the accuracy or likelihood of fulfilment of
any forward looking statement, or any intentions or outcomes expressed or implied in any
forward looking statement and disclaim all responsibility and liability for such forward looking
4
statements (including, without limitation, liability for negligence). The Company has no
intention to update or revise forward-looking statements, or to publish prospective financial
information in the future, regardless of whether new information, future events or any other
factors affect the information contained in this Prospectus, except where required by law. You
are cautioned not to place undue reliance on any forward looking statement having regard to
the fact that the outcome may not be achieved.
Any pro forma financial information (including past performance information) provided in this
Prospectus is for information purposes only and is not a forecast of operating results to be
expected in any future period. Except as required by law, and only then to the extent so
required, neither the Company nor any other person warrants or guarantees the future
performance of the Company or any return on any investment made pursuant to this
Prospectus.
2.10 Risk factors
Potential Applicants should be aware that subscribing for the Options involves a number of
risks. The key risk factors of which potential Applicants should be aware are set out in
Section 8 of this Prospectus. Potential Applicants should carefully consider the risk factors that
affect the Company and the industry in which the Company operates.
2.11 Defined terms, currency and time
Capitalised terms and abbreviations used in this Prospectus are defined in Section 11 of this
Prospectus. References to “I”, “you” and “your” are references to an Applicant.
All financial amounts shown in this Prospectus are expressed in Australian dollars unless
otherwise stated.
Notwithstanding any references to the contrary, all references to time in this Prospectus are
to Sydney, Australia time.
2.12 Past performance
Shareholders should note that past performance, including past Share price performance,
cannot be relied on as an indicator of, and provides no guidance as to, future Company
performance, including future Share performance.
2.13 No cooling-off rights apply to the Offers
Cooling-off rights do not apply to an investment pursuant to any of the Offers. This means that,
in most circumstances, you cannot withdraw your Application once it has been lodged.
2.14 Withdrawal
The Company reserves the right to withdraw the Offers at any time before the issue of Options
under the Offers.
2.15 Enquiries
If you are in any doubt as to how to deal with any of the matters raised in this Prospectus, you
should consult with your broker or legal, financial or other professional adviser without delay.
For enquiries concerning the Offers or how to accept the Offers, please contact the Company
Secretary by email at company.secretary@recce.com.au.
5
3. OVERVIEW OF THE OFFERS
3.1 The Offers
This section is intended to highlight key information for potential investors. Further detail is
set out in this Prospectus. Please read and consider this Prospectus in full before making any
decision regarding applying for the Options.
Topic Summary Where to find more
information
What are the
Offers?
Under this Prospectus, the Company is
offering:
(a) 5,000,000 Placement Attaching
Options, being one Attaching Option
for every two Shares issued to
Placement Participants under the
Placement;
(b) 125,000 Spark Plus Options to Spark
Plus; and
(c) up to 10,250,000 Piggyback Options,
being two Piggyback Options for
every Attaching Option exercised.
Each Attaching Option and each
Piggyback Option is offered for nil
consideration.
Section 4.1.
Why are no
Options being
offered to SPP
Participants?
Shareholders did not approve the issue of
Attaching Options and Piggyback Options to
SPP Participants at the Meeting, and ASX has
advised the Company that it cannot issue
those Options using its placement capacity
under ASX Listing Rule 7.1. No Options are
offered to SPP Participants under this
Prospectus.
Section 4.1(b).
What is the
purpose of the
Offers?
This Prospectus has been issued to make
the Offers and to facilitate secondary
trading of the Shares to be issued on
exercise of the Options.
Section 4.3.
Use of funds.
No funds will be raised as a result of the
Offers.
Section 4.4.
Can I sell or
transfer my
entitlements?
No. The Offers are non-renounceable.
Accordingly, you cannot offer to sell or
transfer your entitlement to subscribe for
Options under any of the Offers. The
Options themselves may only be
transferred with the prior written consent
of the Board.
Section 4.6.
Are the Offers
underwritten?
No, the Offers are not underwritten.
Section 4.9.
What are the
terms of the
Each Attaching Option has an exercise price
of $0.60, expires on 30 June 2027 and,
Section 6.1.
6
Options? upon exercise, entitles the holder to one
Share and two Piggyback Options. Each
Piggyback Option has an exercise price of
$1.00, expires on 30 June 2028 and, upon
exercise, entitles the holder to one Share.
The Options will not be quoted on ASX.
Full terms of the Options are set out in
Section 6.1.
Are there any tax
implications of
participating in
the Offers?
Taxation implications will vary depending
upon the specific circumstances of the
investor. You should obtain professional
advice as to the taxation treatment
applicable to you.
Section 8.3(c).
Are there any
risks associated
with investments
in the Company?
There are risks associated with investment
in the Company. These include risks
relating to the Offers and the Options, risks
associated with financial investment
generally. Please carefully consider the
risks and the information contained in this
Prospectus in conjunction with any specific
matters which have or may be referred to
in the Company's ASX announcements
before deciding to apply for or acquire
Options or otherwise making an investment
in the Company.
Section 8
Where can I find
more information
about the
Company?
For more information on the Company,
please see the Company's website
(https://www.recce.com.au/company-
announcements/) or refer to the
Company's ASX announcements (available
on the ASX's website www.asx.com.au,
search code “RCE”).
See the Important
Information
section above for
further information.
What if I have any
further questions
about the Offers
or how to apply?
You may contact the Company Secretary
via email at
company.secretary@recce.com.au.
See the Important
Information section
above for further
information.
4. DETAILS OF THE OFFERS
4.1 Offers
(a) Placement Attaching Options Offer
On 26 June 2026, the Company announced a placement comprising the issue of
10,000,000 Shares at $0.40 per Share (Placement) to sophisticated, professional and
institutional investors, to raise $4 million (before costs), utilising the Company's
placement capacity under ASX Listing Rule 7.1.
9,850,000 Placement Shares were issued on 1 July 2026 and 150,000 Placement Shares
were issued on 3 July 2026. The Company confirms that no further Shares will be issued
in connection with the Placement.
7
The offer of Attaching Options to Placement Participants is an offer of 5,000,000 new
Attaching Options for nil consideration on the basis of one Attaching Option for every two
Shares issued to Placement Participants under the Placement (Placement Attaching
Options Offer). Where the determination of a Placement Participant's entitlement to
Attaching Options under the Placement Attaching Options Offer results in a fraction, such
fraction will be rounded down to the nearest whole Attaching Option.
Based on the number of Shares issued under the Placement, 5,000,000 Attaching Options
may be issued under the Placement Attaching Options Offer. No funds will be raised from
the issue of the Attaching Options.
The Attaching Options offered under the Placement Attaching Options Offer will be
exercisable at $0.60 each, will expire on 30 June 2027 and are otherwise issued on the
terms set out in Section 6.1.
All of the Shares issued upon exercise of the Options will rank equally with the Shares on
issue at the date of this Prospectus. Please refer to Section 7.1 for further information
regarding the rights and liabilities attaching to the Shares.
(b) SPP Options not offered under this Prospectus
On 26 June 2026, the Company announced a share purchase plan under which eligible
shareholders were invited to subscribe for up to $30,000 worth of new fully paid ordinary
shares (New Shares) at an issue price of $0.40 per New Share, to raise up to $4 million
(before costs) (SPP Offer).
The SPP Offer closed at 5.00pm (AEST) on 24 July 2026 and, as announced on 31 July 2026,
raised approximately $2.4 million through the issue of 6,051,250 New Shares. The
Directors reserve the right to place the shortfall of 3,948,750 New Shares under the SPP
Offer to unrelated professional, sophisticated or institutional investors at their absolute
discretion (SPP Shortfall Offer).
When the Placement and the SPP Offer were announced on 26 June 2026 the Company
said that it intended to offer one Attaching Option for every two New Shares issued under
the SPP Offer and the SPP Shortfall Offer. The share purchase plan booklet released on 6
July 2026 stated that the issue of those Attaching Options, and of the Piggyback Options
arising on their exercise (together, the SPP Options), was subject to Shareholder
approval.
Shareholder approval was sought at the Meeting. Resolution 1, which sought approval
under ASX Listing Rule 7.1 for the issue of 5,000,000 Attaching Options and up to
10,000,000 Piggyback Options arising from the SPP Offer and the SPP Shortfall Offer, was
not carried.
Resolutions 2 to 5, which sought approval under ASX Listing Rule 10.11 for the issue of
Attaching Options and Piggyback Options to each of Dr John Prendergast, Dr Alan Dunton,
Dr Justin Ward and Mr James Graham (or their nominees), were also not carried.
The Company asked ASX to confirm whether it had any objection to the SPP Options being
issued using the Company's placement capacity under ASX Listing Rule 7.1. ASX advised
the Company on 11 September 2026 that, because the issue had been proposed on the
basis that Shareholder approval would be obtained, ASX Listing Rule 7.2 exception 17 and
ASX Listing Rule 14.7 prevent the Company from issuing the SPP Options out of that
capacity.
Accordingly, no SPP Options are offered under this Prospectus and no SPP Participant has
any right or entitlement to be issued an Attaching Option or a Piggyback Option.
8
The Attaching Options offered under the Placement Attaching Options Offer an
Share your feedback
Discover